// App-Quantinova.ai

1521 : Promising Efficacy of Allogeneic Stem Cell Transplantation with Postransplantation Bendamustine in Refractory Acute Myeloid Leukemia: A Dose-Ranging Study

Researchers

Presenter

  • Ivan S. Moiseev

Principal Investigators

  • Julia J. Vlasova

  • Elena V. Morozova

  • Anastasiya Beynarovich

  • Evgeniya Borzenkova

  • Anna Dotcenko

  • Olga Kudyasheva

  • Varvara Nikolaevna Ovechkina

  • Olga Vladislavovna Pirogova

  • Valentina Vladimirovna Porunova

  • Tatiana Rudakova

  • Olesya Smykova

  • Axel R. Zander

  • Sergey N. Bondarenko

Medical Centers

  • RM Gorbacheva Research Institute, Pavlov University,St Petersburg,Russia

  • RM Gorbacheva Research Institute, Pavlov University,St Petersburg,Russia

  • University of Hamburg, Hamburg, Germany

Locations

  • Russia

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Graft-versus-host disease

  • Neutropenia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Bendamustine

  • fludarabine tablet

  • Tacrolimus

  • Busulfan

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • I

Study Id's

  • NCT02799147

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved